Pages that link to "Q39912439"
Jump to navigation
Jump to search
The following pages link to Monoamine oxidase inhibitors. A review of antidepressant effectiveness (Q39912439):
Displaying 50 items.
- Evidence for Broadening Criteria for Atypical Depression Which May Define a Reactive Depressive Disorder (Q26799927) (← links)
- Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336). (Q34262670) (← links)
- Depression With Atypical Features: Diagnostic Validity, Prevalence, and Treatment (Q35667204) (← links)
- Long-term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats (Q35754869) (← links)
- Xanthoangelol and 4-Hydroxyderricin Are the Major Active Principles of the Inhibitory Activities against Monoamine Oxidases on Angelica keiskei K. (Q37314132) (← links)
- Atypical depression: useful concept, but it's time to revise the DSM-IV criteria (Q37594567) (← links)
- Atypical depression: a comprehensive review (Q37643677) (← links)
- Monoamine oxidase inhibitors: clinical review (Q37828375) (← links)
- Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities (Q39380913) (← links)
- L-tryptophan: a rational anti-depressant and a natural hypnotic? (Q39641473) (← links)
- The drug treatment of anxiety and depression. (Q39643048) (← links)
- A clinical overview of monoamine oxidase inhibitors (Q39819004) (← links)
- Selective inhibitors of monoamine oxidase A and B: biochemical, pharmacological, and clinical properties (Q40182942) (← links)
- Atypical depression. (Q40188025) (← links)
- Monoamine oxidase-inhibiting antidepressants. A clinical update. (Q40188029) (← links)
- Nosology of atypical depression. (Q40270669) (← links)
- Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans? (Q40457646) (← links)
- Drug therapy for geriatric depression (Q40822196) (← links)
- Treatment algorithms in treatment-resistant depression (Q41127972) (← links)
- The validity of atypical depression in DSM-IV. (Q41227986) (← links)
- Urinary phenylethylamine correlates positively with hypomania, and negatively with depression, paranoia, and social introversion on the MMPI. (Q41477591) (← links)
- Antidepressant and Antipsychotic Drugs (Q42018725) (← links)
- Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase (Q42224490) (← links)
- Some biochemical aspects of the potential benefit of associating MD780515 with tricyclic antidepressants (Q42241360) (← links)
- Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial (Q42248139) (← links)
- Neurochemical and neuropharmacological properties of 4-fluorotranylcypromine (Q44621370) (← links)
- Predictors of response to monoamine oxidase inhibitors: Do they exist? (Q45184472) (← links)
- The Black Book of Psychotropic Dosing and Monitoring (Q47642128) (← links)
- Clinical chemistry of monoamine oxidase (Q48361622) (← links)
- Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines (Q48897263) (← links)
- Rapid, psychopharmacologically induced improvement can produce new psychological symptoms (Q49020224) (← links)
- Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants (Q49090292) (← links)
- Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate (Q49108051) (← links)
- Reduced accumulation in brain of orally ingested β-phenethylamine after inhibition of type A monoamine oxidase in the rat (Q49153300) (← links)
- Combined antidepressant treatment (Q49509681) (← links)
- MAOA T941G polymorphism and the time course of emotional recovery following unpleasant pictures (Q50699074) (← links)
- Pharmacotherapy response and diagnostic validity in atypical depression (Q51088097) (← links)
- Measurement of temperament and character in mood disorders: a model of fundamental states as personality types (Q51092578) (← links)
- History of separation anxiety in patients with panic disorder and depression and normal controls (Q51176180) (← links)
- Toward validation of atypical depression in the community: results of the Zurich cohort study. (Q51953654) (← links)
- Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule. (Q52270838) (← links)
- Tranylcypromine isomers: single-dose effects in normal human subjects. (Q53868507) (← links)
- Long-term treatment of depression with isocarboxazide. (Q54546129) (← links)
- Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution. (Q54764956) (← links)
- Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression. (Q55132660) (← links)
- Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting (Q57788879) (← links)
- Clinical Note: Limitation and Potential Hazards of MAOI's for the Treatment of Depressive Symptoms in Abstinent Alcoholics (Q58146498) (← links)
- Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant (Q60054797) (← links)
- Interrelationship of Hysteroid Dysphoria and Borderline Personality Disorder (Q60628591) (← links)
- Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or antidepressants (Q67907031) (← links)